An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management

On the Road to an HIV Cure: How Far Have We Come?
Alan L. Landay, PhD

Cases from the Clinic(ians): Case-Based, Panel Discussion
Michael S. Saag, MD

Antiretroviral Therapy (ART): New Drugs and New Guidelines
Roy M. Gulick, MD, MPH

Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection
Andrew I. Aronsohn, MD

Getting Hotter As We Get Older: The Role of Ongoing Inflammation in HIV Infection
Sara Gianella Weibel MD

Clinical Care Conundrums: HIV Patient Care in 2016: A Case-Based, Panel Discussion
Charles B. Hicks, MD

Progress and Pitfalls in Pediatric and Adolescent HIV Infection
Ellen G. Chadwick, MD

Antiretroviral Therapy (ART) New Drugs: The Only Thing that Stays the Same is Change
Joseph J. Eron, MD

Hepatitis C Virus (HCV) Management: Dealing with Treatment Failure (Been There, Done That)
Alexander Monto, MD

When Will It All Be Over? HIV Cure Efforts
Davey M. Smith, MD

Advances in Hepatitis C Virus (HCV) Treatment for HIV-infected Persons: Have We Reached the End of the Rainbow?
Kara W. Chew, MD, MS

The Persistent Challenges of HIV Transmission Control in Injection Drug Use: Lessons from the Indiana Outbreak
Diane M. Janowicz, MD

Clinically Significant Drug Interactions, HIV and Hepatitis C Virus (HCV): How Quickly We Forget!
Jennifer J. Kiser, PharmD

Barriers to HIV Cure
Janet Siliciano, PhD

Ryan White at 25 Years: How an Emergency Program Grew to Become the Nation’s HIV Safety-Net
Jennifer Kates, PhD, MPA

Updates From the Conference on Retroviruses and Opportunistic Infections (CROI)
Henry Masur, MD

A Shot in the Arm for HIV Prevention? Opportunisties and Challenges in 2016
Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA

Cases from the Clinic(ians): Case-Based, Panel Discussion
Michael S. Saag, MD

Psychopharmacology for Every HIV Clinician
Glenn J. Treisman, MD, PhD

Statins, Rainwater, and Pure Grain Alcohol: Cardiovascular Disease Management in 2016
Turner Overton, MD

Persistent Challenges of HIV Transmission Control in Injection Drug Use: Lessons from the Indiana Outbreak
John T. Brooks, MD

Challenges in the Management and Treatment of HIV/HCV Coinfection
Arthur Y. Kim, MD

HIV Cures and Immunotherapy: New Horizons
Daniel C. Douek, MD, PhD

Breaking News From CROI
Jeffrey L. Lennox, MD

HIV Vaccines and Immunoprotection: Where Are We?
Mark J. Mulligan, MD

Hepatitis B Virus (HBV) Infection: A Focus on Cure
Kenneth E. Sherman, MD, PhD

A Case of the Clap: Update on Sexually Transmitted Infections in Patients with HIV-Infection
Kimberly A. Workowski, MD, FACP, FIDSA

Persistent Challenges of HIV Transmission Control in Injection Drug Use: Lessons from the Indiana Outbreak
Diane M. Janowicz, MD

Challenges in the Management and Treatment of HIV/HCV Coinfection
Ricardo A. Franco, MD

The Beginning of the End? Update on Curative Strategies for HIV
Timothy J. Henrich, MD

Treatment as Prevention
Wafaa El-Sadr MD, MPH

Starting and Switching: Modern-Day Antiretroviral Dilemmas: A Case-Based, Panel Discussion
Joel E. Gallant, MD, MPH

Sexually Transmitted Diseases (STDs) and HIV: Top Ten Highlights for Clinicians
Dana W. Dunne MD

Antiretroviral Therapy: What to Start and Investigational New Drugs
Roy M. Gulick, MD, MPH

The Top 5 Things to Remember About Treating Hepatitis C Virus (HCV)
Susanna Naggie, MD, MHS

Emerging Issues in HIV, Aging, and Cognition
Victor G. Valcour, MD, PhD

Investigational Agents for HCV: I Thought This Was Going To Get Easier
Susanna Naggie, MD, MHS

Chronic Pain in Patients with HIV: What Clinicians Need to Know
Jessica Merlin, MD, MBA

New Guidelines, Strategies, and Drugs for Initiation of Antiretroviral 2013
Charles B. Hicks, MD

Hepatitis C Virus (HCV) Coinfection: Don’t Stand Still Just Because the Landscape Looks Better
Stuart C. Ray, MD

Treatment of HCV Coinfection: Navigating the Interactions
Jennifer J. Kiser, PharmD

Antiretroviral Therapy: Challenging Patients and Difficult Problems
Joel E. Gallant, MD, MPH

Aging and HIV
David A. Wohl, MD

Implications of the Patient Protection and Affordable Care Act and the Status of the Ryan White HIV/AIDS Programs: What Does the Future Hold?
Jennifer Kates, PhD, MPA

Update on Pre-Exposure Prophylaxis: Never a Dull Moment
Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA

Hepatitis C Virus (HCV) Coinfection: New Drugs, New Strategies
Marion G. Peters MD

Antiretrovirals in the Management of HIV Infection: Case-Based, Panel Discussion
Eric S. Daar, MD

Immune Activation, HIV Persistence, and the Cure
Daniel C. Douek, MD, PhD

Conference on Retroviruses and Opportunistic Infections 2013: Focus on ART
Roy M. Gulick, MD, MPH

Anal Cancer and HIV: A Debate on Screening
Jeffrey L. Lennox, MD; Kimberly A. Workowski, MD, FACP, FIDSA

Emerging Issues in HIV, Aging and Cognition
Victor G. Valcour, MD, PhD

Challenges in the Management of Osteoporosis and Vitamin D Deficiency in the HIV-Infected Patient
Todd T. Brown, MD, PhD

Don’t Blink: The Rapid Evolution of Interferon Alfa-Free Therapy for Hepatitis C Virus Infection
David L. Wyles, MD

Immune Activation, HIV Persistence, and the Cure
Daniel C. Douek, MD, PhD

Treatment as Prevention: The Key to an AIDS-Free Generation
Julio S. Montaner, MD

Affordable Care Act: What an HIV Provider Needs to Know
Steve O’Brien, MD

Antiretroviral Therapy: A Case-Based Panel Discussion (Part I)
Michael S. Saag, MD; Eric S. Daar, MD

Chronic Pain and the Drug-Seeking Patient: A Behaviorist Approach
Glenn J. Treisman, MD, PhD

Non–AIDS-Defining Cancers in HIV
Ronald T. Mitsuyasu, MD

Antiretroviral Therapy: A Case-Based Panel Discussion (Part II)
Eric S. Daar, MD; Michael S. Saag, MD